Invention Grant
- Patent Title: Interleukin-2 fusion proteins and uses thereof
-
Application No.: US15695899Application Date: 2017-09-05
-
Publication No.: US10562949B2Publication Date: 2020-02-18
- Inventor: Ralf Hosse , Christian Klein , Ekkehard Moessner , Laurence Bernard Peterson , Pablo Umana , Linda Wicker
- Applicant: Roche Glycart AG
- Applicant Address: CH Schlieren
- Assignee: Roche Glycart AG
- Current Assignee: Roche Glycart AG
- Current Assignee Address: CH Schlieren
- Agent Jonathan P. Aumais
- Main IPC: A61K38/20
- IPC: A61K38/20 ; C07K14/55 ; C07K16/46 ; C07K16/18
Abstract:
The present invention generally relates to fusion proteins of immunoglobulins and interleukin-2 (IL-2). In addition, the present invention relates to polynucleotides encoding such fusion proteins, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the fusion proteins of the invention, and to methods of using them in the treatment of disease.
Public/Granted literature
- US20180009868A1 INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF Public/Granted day:2018-01-11
Information query
IPC分类:
